Columbia Care Inc: Overlooked U.S. Pot Stock Reports Record Q2

哥伦比亚护理公司:被忽视的美国第二季度大麻库存报告创纪录

2021-08-16 23:30:24 PROFIT

本文共1812个字,阅读需5分钟

With a market cap of $1.4 billion, Columbia Care Inc isn’t exactly a tiny U.S. pot stock. At the same time, it isn’t a marijuana play that you hear pot investors talking about much. But they should be. Over the last couple of months alone, Columbia Care has announced: This helps explain why Columbia Care’s share price has been on a great trajectory since bottoming in March 2020. Since then, Columbia Care stock has rallied 498%. Furthermore, CCHWF stock is up 32% year-over-year. The company’s share price has traded in a tight range over the last couple of months, but there is plenty of room for growth. Columbia Care stock needs to climb 70% to reach its February 2021 record high of $7.89. A round of additional record financial results could be just what CCHWF stock needs to get there. Chart courtesy of StockCharts.com Columbia Care Inc is one of the largest cultivators, manufacturers, and providers of cannabis products and related services with licenses in 18 jurisdictions (including California, Colorado, Ohio, Illinois, Massachusetts, New York, and Pennsylvania), and Europe. (Source: “Investor Presentation Second Quarter 2021,” Columbia Care Inc., last accessed August 12, 2021.) The company operates 99 U.S. dispensaries (73 active and 26 under development), 31 U.S. cultivation and manufacturing facilities (covering two million-plus square feet), more than 300 acres of outdoor cultivation capacity, and wholesale distribution in 13 operational markets. As one of the largest and most experienced multi-state operators, Columbia Care’s strategic footprint encompasses more than 53% of the U.S. population. Not only that, but Columbia Care Inc was one of the original providers of medical marijuana in the U.S. This experience has helped it seamlessly transition to recreational sales. The company has experienced top-line revenue growth by three to four times in states that have already converted from medical-use to adult-use. And with more and more states legalizing recreational cannabis use, the company continues to have excellent upside potential. Adult-use sales have begun in Arizona and are expected in New Jersey in 2021, New York in 2022, and Virginia in 2024. The company offers products like flower, edibles, oils, and tablets. It also manufactures popular brands such as “Seed & Strain,” “Triple Seven,” “gLeaf,” “Classix,” “Plant Sugar,” “Press,” “Amber,” and “Platinum Label CBD.” In May 2021, Columbia Care launched “Cannabist,” its new retail brand, creating a national dispensary network. In April, the first dispensary to launch under the Cannabist brand was in Springville, UT. By the end of May, three existing Columbia Care locations in Tempe, AZ, Villa Park, IL, and San Diego, CA became Cannabist-branded retail locations. The company has a pipeline of more than 80 new and existing locations to follow over the next 24 months. For the second quarter, which ended June 30, 2021, Columbia Care announced that revenue jumped 232% year-over-year and 19% sequentially to a record $109.7 million. (Source: “Columbia Care Reports Record Second Quarter 2021 Results,” Columbia Care Inc., August 12, 2021.) The company reported a second-quarter net loss of $10.8 million, or a loss of $0.03 per share, versus a second-quarter 2020 net loss of $27.3 million, or $0.11 per share. Columbia Care announced that quarterly adjusted gross profit increased 300% increase year-over-year and 26% sequentially to a record $47.7 million. It also reported record adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $16.5 million. This figure represents a $21.1-million increase year-over-year, up 58% quarter-over-quarter. Columbia Care Inc reaffirmed its 2021 revenue guidance of $500.0 million to $530.0 million and adjusted EBITDA guidance of $95.0 million to $105.0 million. In 2020, the company reported record revenue of $197.9 million and an adjusted EBITDA loss of nearly $1.0 million. (Source: “Columbia Care Reports Record Fourth Quarter and Full Year 2020 Results; Reaffirms 2021 Guidance,” Columbia Care Inc., March 16, 2021.) During the quarter, the company raised $74.5 million of six percent convertible debt and ended the quarter with a cash balance of $149.2 million. Columbia Care Inc is an excellent, overlooked U.S. cannabis company with a strong balance sheet and one of the largest national footprints. It also reported another quarter of record financial results and reaffirmed its full-year guidance. And the outlook remains bright for Columbia Care. The company has additional growth initiatives underway. With New York, New Jersey, and Virginia poised to transition to adult use, the opportunities for Columbia Care remain robust. This has set the stage for a far-reaching second half of the year, with momentum building into 2022. With all things being equal, this should result in record-breaking 2021 and 2022 financial results.
Columbia Care Inc.(CNSX:CCHW,OTCMKTS:CCHWF)的市值为14亿美元,并不完全是美国的小股。与此同时,这并不是大麻投资者经常谈论的大麻游戏。但他们应该是。 仅在过去的几个月里,哥伦比亚护理公司就宣布: 这有助于解释为什么哥伦比亚护理公司的股价自2020年3月触底以来一直处于良好的轨迹。自那以后,哥伦比亚护理公司的股票已经上涨了498%。此外,CCHWF的股票同比增长32%。 在过去的几个月里,该公司的股价一直在一个狭窄的区间内交易,但有很大的上涨空间。哥伦比亚护理公司的股票需要上涨70%,才能达到2021年2月7.89美元的创纪录高点。新一轮创纪录的财务业绩可能正是CCHWF股票实现这一目标所需要的。 图表由stockcharts.com提供 哥伦比亚护理公司是大麻产品和相关服务的最大种植者、制造商和提供者之一,在18个司法管辖区(包括加利福尼亚州、科罗拉多州、俄亥俄州、伊利诺伊州、马萨诸塞州、纽约州和宾夕法尼亚州)和欧洲拥有许可证。(来源:哥伦比亚护理公司(Columbia Care Inc.)“2021年第二季度投资者陈述”,最后一次访问是2021年8月12日。) 该公司在美国经营99个药房(73个活跃,26个正在开发中),31个种植和生产设施(占地200多万平方英尺),300多英亩的户外种植能力,并在13个运营市场进行批发分销。 作为最大和最有经验的多州运营商之一,哥伦比亚护理公司的战略足迹涵盖了超过53%的美国人口。 不仅如此,哥伦比亚护理公司还是美国医用大麻的最初供应商之一。这种经历帮助它无缝地过渡到娱乐销售。在已经从医疗用途转向成人用途的州,该公司的收入增长了三到四倍。 随着越来越多的州将娱乐性大麻使用合法化,该公司继续具有极好的上升潜力。亚利桑那州已经开始销售成人用品,预计2021年在新泽西州,2022年在纽约,2024年在弗吉尼亚州。 该公司提供花卉、食品、油和药片等产品。它还生产流行的品牌,如“种子和菌株”,“三重七”,“Gleaf”,“Classix”,“植物糖”,“Press”,“Amber”和“CBD白金标签”。 2021年5月,哥伦比亚护理公司推出了其新零售品牌“大麻”,创建了一个全国药房网络。今年4月,第一家以大麻品牌推出的药房在犹他州的斯普林维尔。 到5月底,位于亚利桑那州坦佩、伊利诺伊州维拉公园和加利福尼亚州圣地亚哥的三个现有哥伦比亚护理中心成为大麻品牌零售点。在接下来的24个月里,该公司将有80多个新的和现有的地点。 截至2021年6月30日的第二季度,哥伦比亚护理公司宣布收入同比增长232%,并依次增长19%,达到创纪录的1.097亿美元。(来源:《哥伦比亚护理报告创纪录的2021年第二季度业绩》,哥伦比亚护理公司,2021年8月12日。) 该公司报告第二季度净亏损1080万美元,或每股亏损0.03美元,而2020年第二季度净亏损2730万美元,或每股亏损0.11美元。 哥伦比亚护理公司宣布,季度调整后毛利同比增长300%,并连续增长26%,达到创纪录的4770万美元。 该公司还公布了创纪录的利息、税项、折旧和摊销前调整利润(EBITDA)为1650万美元。这一数字同比增长2110万美元,环比增长58%。 哥伦比亚护理公司重申其2021年收入指导为5.00亿美元至5.3亿美元,调整后的EBITDA指导为9500万美元至1.05亿美元。2020年,该公司报告创纪录的收入1.979亿美元,经调整EBITDA亏损近100万美元。(来源:“哥伦比亚护理公司报告创纪录的2020年第四季度和全年业绩;重申2021年指南,”哥伦比亚护理公司,2021年3月16日。) 在本季度,该公司筹集了7450万美元的6%可转换债务,本季度结束时现金余额为1.492亿美元。 哥伦比亚护理公司是一家优秀的、被忽视的美国大麻公司,拥有强大的资产负债表和最大的全国足迹之一。该公司还报告了另一个季度创纪录的财务业绩,并重申了全年指导方针。 哥伦比亚护理公司的前景仍然光明。该公司正在进行额外的增长计划。随着纽约、新泽西和弗吉尼亚准备向成人使用过渡,哥伦比亚护理的机会仍然很大。 这为影响深远的下半年奠定了基础,并将势头持续到2022年。在一切平等的情况下,这应该会导致2021年和2022年创纪录的财务业绩。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文